IBDEI0LN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9739,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,9740,0)
 ;;=R63.0^^39^417^13
 ;;^UTILITY(U,$J,358.3,9740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9740,1,3,0)
 ;;=3^Anorexia
 ;;^UTILITY(U,$J,358.3,9740,1,4,0)
 ;;=4^R63.0
 ;;^UTILITY(U,$J,358.3,9740,2)
 ;;=^7939
 ;;^UTILITY(U,$J,358.3,9741,0)
 ;;=R87.611^^39^417^2
 ;;^UTILITY(U,$J,358.3,9741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9741,1,3,0)
 ;;=3^ASC-H
 ;;^UTILITY(U,$J,358.3,9741,1,4,0)
 ;;=4^R87.611
 ;;^UTILITY(U,$J,358.3,9741,2)
 ;;=^5019669
 ;;^UTILITY(U,$J,358.3,9742,0)
 ;;=R87.610^^39^417^3
 ;;^UTILITY(U,$J,358.3,9742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9742,1,3,0)
 ;;=3^ASC-US
 ;;^UTILITY(U,$J,358.3,9742,1,4,0)
 ;;=4^R87.610
 ;;^UTILITY(U,$J,358.3,9742,2)
 ;;=^5019668
 ;;^UTILITY(U,$J,358.3,9743,0)
 ;;=Z98.82^^39^417^14
 ;;^UTILITY(U,$J,358.3,9743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9743,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,9743,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,9743,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,9744,0)
 ;;=B37.3^^39^417^15
 ;;^UTILITY(U,$J,358.3,9744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9744,1,3,0)
 ;;=3^Candidiasis of Vulva & Vagina
 ;;^UTILITY(U,$J,358.3,9744,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,9744,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,9745,0)
 ;;=D06.9^^39^417^16
 ;;^UTILITY(U,$J,358.3,9745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9745,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Unspec
 ;;^UTILITY(U,$J,358.3,9745,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,9745,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,9746,0)
 ;;=D06.0^^39^417^17
 ;;^UTILITY(U,$J,358.3,9746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9746,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,9746,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,9746,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,9747,0)
 ;;=D06.1^^39^417^18
 ;;^UTILITY(U,$J,358.3,9747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9747,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,9747,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,9747,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,9748,0)
 ;;=A56.02^^39^417^19
 ;;^UTILITY(U,$J,358.3,9748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9748,1,3,0)
 ;;=3^Chlamydial Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,9748,1,4,0)
 ;;=4^A56.02
 ;;^UTILITY(U,$J,358.3,9748,2)
 ;;=^5000340
 ;;^UTILITY(U,$J,358.3,9749,0)
 ;;=N81.12^^39^417^22
 ;;^UTILITY(U,$J,358.3,9749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9749,1,3,0)
 ;;=3^Cystocele,Lateral
 ;;^UTILITY(U,$J,358.3,9749,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,9749,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,9750,0)
 ;;=N81.11^^39^417^23
 ;;^UTILITY(U,$J,358.3,9750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9750,1,3,0)
 ;;=3^Cystocele,Midline
 ;;^UTILITY(U,$J,358.3,9750,1,4,0)
 ;;=4^N81.11
 ;;^UTILITY(U,$J,358.3,9750,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,9751,0)
 ;;=N81.10^^39^417^24
 ;;^UTILITY(U,$J,358.3,9751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9751,1,3,0)
 ;;=3^Cystocele,Unspec
 ;;^UTILITY(U,$J,358.3,9751,1,4,0)
 ;;=4^N81.10
 ;;^UTILITY(U,$J,358.3,9751,2)
 ;;=^5015838
 ;;^UTILITY(U,$J,358.3,9752,0)
 ;;=R87.614^^39^417^25
 ;;^UTILITY(U,$J,358.3,9752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9752,1,3,0)
 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
 ;;^UTILITY(U,$J,358.3,9752,1,4,0)
 ;;=4^R87.614
